Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
4
Number of overlapping holdings
10.3%
% of IBRN's 62 holdings also in PBE
14.3%
% of PBE's 32 holdings also in IBRN
Overlap by Weight
Sector Drift (IBRN minus PBE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBRN |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
 |
NEUROCRINE BIOSCIENCES INC | 3.6% | 4.1% | 3.6% |
|
BIOGEN IDEC INC | 3.4% | 4.9% | 3.4% |
|
ACADIA PHARMACEUTICALS INC | 4.3% | 2.9% | 2.9% |
|
CATALYST PHARMACEUTICAL PART | 4.2% | 2.8% | 2.8% |
Position Highlights (Non-Overlapping Exposures)
IBRN Overweight Relative to PBE
 |
ARGENX SE ADR | 5.6% |
 |
ALKERMES PLC | 4.5% |
 |
SK BIOPHARMACEUTICALS CO., LTD. | 4.5% |
|
INTRA-CELLULAR THERAPIES INC | 4.3% |
|
DYNE THERAPEUTICS INC | 4.3% |
|
AXONICS MODULATION TECHNOLOGIES, INC | 4.0% |
|
SAREPTA THERAPEUTICS INC | 4.0% |
|
PTC THERAPEUTICS INC | 3.7% |
|
SUPERNUS PHARMACEUTICALS INC | 3.4% |
|
CASSAVA SCIENCES, INC. | 2.6% |
IBRN Underweight Relative to PBE
|
AMGEN INC | -5.2% |
|
ILLUMINA INC | -5.1% |
|
UNITED THERAPEUTICS CORP | -5.0% |
|
REGENERON PHARMACEUTICALS | -4.9% |
|
ALNYLAM PHARMACEUTICALS INC | -4.8% |
|
BIOMARIN PHARMACEUTICAL INC | -4.8% |
|
XENCOR INC | -3.5% |
|
NOVAVAX INC | -3.4% |
|
PROTAGONIST THERAPEUTICS, INC. | -3.1% |
|
NATERA INC | -2.9% |